The Patent Finder

Jounce Therapeutics, Inc.

Also on record
Records under this name other than the patents Jounce Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 7 of 7 · Back to Jounce Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,692,038Antibodies That Bind Chemokine (C-C Motif) Receptor 8 (CCR8)
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,297,282Nucleic Acids Encoding, and Methods of Producing, Antibodies That Bind Human Chemokine (C-C Motif) Receptor 8 (CCR8)
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,023,635Antibodies to Icos
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 11,384,147Anti-PD-1 Antibodies and Uses Thereof
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 11,359,019Antibodies to LILRB2
Lapsed on the fee record
Ended Jun 14, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2026USPTO record
US 11,292,840Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist
Lapsed on the fee record
Ended Apr 5, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 5, 2026USPTO record
US 10,968,277Gene signatures for determining ICOS expression
Lapsed on the fee record
Ended Apr 6, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 6, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited